In our previous investigation using another xCT inhibitor, sulfasalazine, we demonstrated that the pretreatment with sulfasalazine decreased intratumoral glutathione concentration, induced a high frequency of cellular DNA damage indicated by γ-H2AX staining, and an enhanced susceptibility to radiotherapy in mouse melanoma [47]. This evidence concerns the gene H2AX and melanoma.